Institutional Repository of Chinese Acad Sci, Inst Automat, CAS Key Lab Mol Imaging, Beijing 100190, Peoples R China
Y-1 receptor ligand-based nanomicelle as a novel nanoprobe for glioma-targeted imaging and therapy | |
Li, Juan1,2; Du, Yang3; Jiang, Zhenqi1,2,4; Tian, Yuchen1,2; Qiu, Nianxiang1,2; Wang, Yinjie1,2,4; Lqbal, Muhammad Zubair1,2; Hu, Menying1,2; Zou, Ruifen1,2,4; Luo, Lijia1,2,4; Du, Shiyu1,2; Tian, Jie3; Wu, Aiguo1,2 | |
发表期刊 | NANOSCALE |
2018-04-07 | |
卷号 | 10期号:13页码:5845-5851 |
文章类型 | Article |
摘要 | Due to the molecular and cellular heterogeneity of glioma, discovery of novel targeted sites and ligands for glioma imaging and therapy remains challenging. Neuropeptide Y (NPY) Y-1 receptors (Y(1)Rs) are highly over expressed in various brain tumors including glioma, and can serve as potential targeting sites for glioma imaging and therapy. Here, we show by in vivo fluorescent imaging that a highly selective Y1R ligand, [Asn(6), Pro(34)] NPY (AP-NPY), facilitated circumvention of the blood brain barrier (BBB) by nanomicelles specifically targeting glioma. Modification with AP-NPY stabilized doxorubicin-loaded nanomicelles in the normal physiological state and promoted drug release in the acidic tumor microenvironment. Furthermore, targeted delivery of AP-NPY nanomicelles improved the therapeutic efficacy of doxorubicin for glioma, producing a prolonged survival rate. These results suggest that Y1R is a novel targeted receptor, and its selective ligand AP-NPY improves BBB permeability and glioma targeting. Our study paves the way for developing a novel delivery system for diagnosis and treatment of glioma in which Y(1)Rs are over expressed. |
WOS标题词 | Science & Technology ; Physical Sciences ; Technology |
DOI | 10.1039/c8nr00148k |
关键词[WOS] | BLOOD-BRAIN-BARRIER ; NEUROPEPTIDE-Y RECEPTORS ; BREAST-CANCER ; TUMOR HETEROGENEITY ; DRUG-DELIVERY ; HIGH-GRADE ; NANOPARTICLES ; INTERNALIZATION ; Y-1-RECEPTOR ; PERMEABILITY |
收录类别 | SCI |
语种 | 英语 |
项目资助者 | Natural Science Foundation of China(51303196 ; Science and Technology Department of Zhejiang Province(2016C33093 ; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase)(U1501501) ; Youth Innovation Promotion Association Foundation, CAS(2017340) ; Strategic Priority Research Program from Chinese Academy of Sciences(XDB02060010) ; International Innovation Team of CAS(20140491524) ; Bureau of Science and Technology of Ningbo Municipality City(2015C50004 ; Beijing Municipal Science & Technology Commission(Z161100002616022) ; U1432114 ; 2017C33129 ; 2015B11002 ; 81227901 ; 2017C03042 ; 2017C110022) ; 81527805 ; LY18H180011) ; 61231004 ; 81470083) |
WOS研究方向 | Chemistry ; Science & Technology - Other Topics ; Materials Science ; Physics |
WOS类目 | Chemistry, Multidisciplinary ; Nanoscience & Nanotechnology ; Materials Science, Multidisciplinary ; Physics, Applied |
WOS记录号 | WOS:000428788200007 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.ia.ac.cn/handle/173211/22020 |
专题 | 中国科学院分子影像重点实验室 |
作者单位 | 1.Chinese Acad Sci, Ningbo Inst Mat Technol & Engn, CAS Key Lab Magnet Mat & Devices, Key Lab Addit Mfg Mat Zhejiang Prov, Ningbo 315201, Zhejiang, Peoples R China 2.Chinese Acad Sci, Ningbo Inst Mat Technol & Engn, Div Funct Mat & Nanodevices, Ningbo 315201, Zhejiang, Peoples R China 3.Chinese Acad Sci, Inst Automat, Sate Key Lab Management & Control Complex Syst, CAS Key Lab Mol Imaging, Beijing 100190, Peoples R China 4.Univ Chinese Acad Sci, Beijing 100049, Peoples R China |
推荐引用方式 GB/T 7714 | Li, Juan,Du, Yang,Jiang, Zhenqi,et al. Y-1 receptor ligand-based nanomicelle as a novel nanoprobe for glioma-targeted imaging and therapy[J]. NANOSCALE,2018,10(13):5845-5851. |
APA | Li, Juan.,Du, Yang.,Jiang, Zhenqi.,Tian, Yuchen.,Qiu, Nianxiang.,...&Wu, Aiguo.(2018).Y-1 receptor ligand-based nanomicelle as a novel nanoprobe for glioma-targeted imaging and therapy.NANOSCALE,10(13),5845-5851. |
MLA | Li, Juan,et al."Y-1 receptor ligand-based nanomicelle as a novel nanoprobe for glioma-targeted imaging and therapy".NANOSCALE 10.13(2018):5845-5851. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论